European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria

Watch
Boehringer Ingelheim RCV GmbH & Co. KG

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Boehringer Ingelheim RCV GmbH & Co. KG

Identification

Fb
Firmenbuch 312077m
Lei
529900WGDQUZBNJOLD52
EUID
ATBRA.312077-000

Address

Dr. Boehringer-Gasse 5-11, 1121 Wien, Austria

Corporate purpose

Production, filling and packaging of various substances and preparations, in particular substances and preparations for medicinal use use, as well as trade in goods of all kinds, in particular with all substances and preparations for medicinal use are determined.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
17Authorized signatory (ppa)
1General partner
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
CSV export

Investigative Journalism

Uncover International Corporate Connections
with our Free Investigative-Account

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
3 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Real estate
Total public funding
Patents
Number of public fundings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2022 to 2025
Profit & Loss
from 2022 to 2025
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

17 Oct 2026
Authorized signatory (ppa): Andrea Dillenz
17 Sept 2026
Annual report for the year ending 31/12/2025 · Balance sheet for 31/12/2025 · Earnings statement for 31/12/2025
9 Sept 2026
Patent: Recombinant host cell manipulated to overexpress helper proteins
29 Aug 2026
Authorized signatory (ppa): Matthias Annefeld, Birgit Giokalas
26 Jun 2026
No longer Authorized signatory (ppa) (2)
18 Jun 2026 in Hor
EU funding: Training program to engage flexible and disordered protein targets for therapeutic development: The oncogene β-catenin as showcase.
17 Jun 2026 in Hor
EU funding: Decoding the dark proteome through interdisciplinary training and research
24 Apr 2026
No longer Authorized signatory (ppa): Dirk Marc J. Rommens · Authorized signatory (ppa) (12)
2 Apr 2026
Authorized signatory (ppa): Marcus A. Kitzer · No longer Authorized signatory (ppa): M. Gibović-Danner
25 Mar 2026 in Sat
State Aid (€2,440,790): FFG Industry Guideline 2024-2026
20 Feb 2026 via C.H. Boehringer Sohn AG & Co. KG also 02/05/2025, 02/10/2024, 08/04/2024, 21/12/2022, 22/12/2021, 15/12/2020, 08/01/2020, 13/12/2018, 03/01/2018, 12/01/2017, 25/02/2016, 17/04/2015, 14/05/2014, 14/02/2013, 16/12/2011, 21/12/2010, 22/12/2009
Shareholder: C.H. Boehringer Sohn AG & Co. KG
30 Jan 2026
Authorized signatory (ppa): Silke Erna Lüdtke · No longer Authorized signatory (ppa): Tilman Carlo Rock
12 Jan 2026 via Boehringer Ingelheim International GmbH also 05/02/2025, 16/02/2024, 13/03/2023, 12/01/2022, 08/12/2011, 10/01/2011
Shareholder: Boehringer Ingelheim International GmbH
20 Nov 2025
Authorized signatory (ppa): Joana Martins
19 Nov 2025
Authorized signatory (ppa): Robert Heinrich Hof · No longer Authorized signatory (ppa): Christina D. H. Wald
5 Nov 2025
Patent: Real-time monitoring of product cleaning
21 Oct 2025
No longer Authorized signatory (ppa): Julian Righetti
2 Oct 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
20 Aug 2025
Authorized signatory (ppa): Harald Freudenthaler · No longer Authorized signatory (ppa): Frieder Gnad-Badouin
28 Mar 2025 in Sat
State Aid (€871,639): FFG Industry Guideline 2024-2026
25 Dec 2024
Patent: Method for the production of a recombinant protein on a production scale
18 Dec 2024 in Sat
State Aid (€177,871): Environmental promotion in Germany Energy efficiency
13 Nov 2024
Patent: Tags for Enhanced Expression of Recombinant Proteins
15 Oct 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
3 Aug 2024
Authorized signatory (ppa) (5) · No longer Authorized signatory (ppa) (1)
17 Jul 2024 via Academisch Ziekenhuis Leiden
EU funding (€270,331): Deconstructing adaptive evolution of metastasis
15 May 2024 in Sat
State Aid (€684,184): FFG Industry Guideline 2024-2026
15 May 2024 in Sat
State Aid (€2,721,679): FFG Industry Guideline 2024-2026
9 Feb 2024
Authorized signatory (ppa): Paul John Adam · No longer Authorized signatory (ppa) (1)
9 Feb 2024
Authorized signatory (ppa): M. Gibović-Danner · No longer Authorized signatory (ppa) (1)
9 Feb 2024
Authorized signatory (ppa): Frieder Gnad-Badouin, Magnus Hargitai
15 Dec 2023
Patent: Means and Methods for Increased Protein Expression by Using a Combination of Transport Proteins and Chaperones or Transcription Factors
25 Oct 2023
Patent: Recombinant host cell manipulated for overexpression of helper proteins
15 Sept 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
15 Sept 2023
Authorized signatory (ppa): Sarah B. Büchner
30 Jun 2023
No longer Authorized signatory (ppa) (1)
31 Mar 2023
Authorized signatory (ppa): Silvia Kainer
22 Mar 2023
Authorized signatory (ppa): Christina D. H. Wald
13 Feb 2023 in Sat
State Aid (€681,023): FFG Industry Guideline, 2022
13 Feb 2023 in Sat
State Aid (€2,645,704): FFG Industry Guideline, 2022
11 Feb 2023
Authorized signatory (ppa): Julian Righetti · No longer Authorized signatory (ppa) (1)
26 Jan 2023
No longer Authorized signatory (ppa) (1)
9 Sept 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
23 Aug 2022 via AB Enzymes GmbH
EU funding (€270,331): Greener, more sustainable platforms for high-value recombinant protein production
24 May 2022
Authorized signatory (ppa): Tilman Carlo Rock · No longer Authorized signatory (ppa) (1)
18 Mar 2022 in Sat
State Aid (€2,476,998): FFG Industry Guideline, 2022
1 Mar 2022
Patent: Neue Adsorbenszusammensetzung und Ihre Anwendung
25 Feb 2022
Authorized signatory (ppa): Dirk Marc J. Rommens
25 Feb 2022
Authorized signatory (ppa): Georg Klima · No longer Authorized signatory (ppa) (1)
11 Feb 2022
Patent: Signal Peptides for Increased Protein Secretion
20 Dec 2021 in Sat
State Aid (€635,700): FFG-RL Industry, Extension
8 Dec 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
1 Sept 2021
Authorized signatory (ppa) (1)
25 Aug 2021
No longer Authorized signatory (ppa) (1)
9 Mar 2021
No longer Authorized signatory (ppa) (1)
29 Dec 2020
No longer Authorized signatory (ppa) (1)
Year 2020 in Sat
4 State Aids (total €2,914,900): promotion of applied research, development and innovation on the basis of the Austrian Research Promotion Agency (mbH) …
24 Oct 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
11 Sept 2020 in Hor
EU funding (€264,207): Deconstructing the evolution of metastasis
14 Aug 2020
Authorized signatory (ppa): Philipp von Hülsen, Rainer Zelbacher
14 Aug 2020
Patent: Caspase-2 Variants
Year 2019 in Epobase
5 European patent filings: Inducible Expression System for Plasmid-Free Production of a Protein of Interest …
5 Sept 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
Year 2019 in Sat
5 State Aids (total €2,528,300): promotion of applied research, development and innovation on the basis of the Austrian Research Promotion Agency (mbH) …
29 Jun 2019
Authorized signatory (ppa) (1)
21 May 2019
No longer Authorized signatory (ppa) (1)
26 Feb 2019
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
26 Feb 2019
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
Year 2018 in Sat
6 State Aids (total €4,676,337): FFG-RL Offensiv …
14 Nov 2018 via Biomin Holding GmbH
EU funding (€264,207): A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes
Year 2018 in Epobase
5 European patent filings: Method for Producing a Recombinant Protein of Interest …
4 Sept 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
24 Jul 2018
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
10 Nov 2017
Patent: Process for Desalting of a Protein Solution
4 Oct 2017
Patent: Method for producing a recombinant protein of interest
19 Sept 2017
Annual report for the year ending 31/12/2016 (only announcement)
28 Aug 2017 in Hor
EU funding: Targeting the metabolism-immune system connections in Cancer
15 May 2017 in Sat
State Aid (€1,023,200): promotion of applied research, development and innovation on the basis of the Austrian Research Promotion Agency (mbH)
15 May 2017 in Sat
State Aid (€47,235): promotion of applied research, development and innovation on the basis of the Austrian Research Promotion Agency (mbH)
14 Apr 2017
Authorized signatory (ppa) (1)
8 Mar 2017
No longer Authorized signatory (ppa) (5) · Authorized signatory (ppa) (2)
21 Oct 2016
Authorized signatory (ppa) (1)
22 Sept 2016
Annual report for the year ending 31/12/2015 (only announcement)
16 Jun 2016
No longer Authorized signatory (ppa): Claudia Gogg
29 Apr 2016
Patent
Year 2015 in Dpmap
13 patent filings: Rekombinante Wirtszelle zur Expression von Zielproteinen …
15 Oct 2015 via Dr.Karl Thomae GmbH also 23/03/2015
Shareholder: Dr.Karl Thomae GmbH
5 Sept 2015
Authorized signatory (ppa) (1)
2 Sept 2015
Annual report for the year ending 31/12/2014 (only announcement)
Year 2015 in Epobase
5 European patent filings: Host-Vector System for Antibiotic-Free Cole1 Plasmid Propagation …
19 Jun 2015
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
Year 2014 in Epobase
4 European patent filings: Production of Recombinant Proteins by Autoproteolytic Cleavage of a Fusion Protein …
24 Jul 2014
Annual report for the year ending 31/12/2013 (only announcement)
17 Jul 2014
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
Year 2014 in Dpmap
4 patent filings: Verfahren zur Herstellung eines Rekombinanten Proteins von Interesse …
1 May 2014
Authorized signatory (ppa) (1)
1 May 2014
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
17 Mar 2014 via Boehringer Ingelheim Verwaltungs GmbH also 07/12/2012
Shareholder: Boehringer Ingelheim Verwaltungs GmbH
30 Jan 2014
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
12 Oct 2013
Annual report for the year ending 31/12/2012 (only announcement)
28 Jun 2013
Authorized signatory (ppa) (1)
13 Jun 2013
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
Year 2012 in Epobase
4 European patent filings: Method for Producing a Recombinant Protein of Interest …
24 Aug 2012
Annual report for the year ending 31/12/2011 (only announcement)
12 Jul 2012
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
10 Jul 2012
Authorized signatory (ppa) (1)
5 Jun 2012
No longer Authorized signatory (ppa) (1)
3 May 2012
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
26 Jan 2012
No longer Authorized signatory (ppa) (1)
16 Sept 2011
Annual report for the year ending 31/12/2010 (only announcement)
16 Sept 2011
Authorized signatory (ppa): Claudia Gogg
17 Aug 2011
No longer Authorized signatory (ppa) (2)
3 Jun 2011
Patent: Transcription Terminator Sequences
31 May 2011
No longer Authorized signatory (ppa) (1)
11 Feb 2011
Annual report for the year ending 31/12/2009 (only announcement)
10 Dec 2010
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
27 Jul 2010
Annual report for the year ending 31/12/2008 (only announcement)
16 Jul 2010
Patent
14 Jul 2010
Patent: Plasmid Maintenance
9 Jul 2010
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
29 Apr 2010
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
24 Mar 2010
Patent: Affinity Ligands
8 Oct 2009
Annual report for the year ending 31/12/2008 (only announcement)
9 Sept 2009
Patent: FED-Batch Fermentation Process and Culture Medium for the Production of Plasmid DNA in E.Coli on a Manufacturing Scale
29 Apr 2009
Authorized signatory (ppa) (1)
17 Mar 2009
Limited Partner: Boehringer Ingelheim Europe GmbH · No longer Limited Partner: Boehringer Ingelheim Auslandsbeteiligungs GmbH · Capital: €9,450,000
16 Jan 2009
Authorized signatory (ppa) (1)
26 Jun 2008
Reg­is­tra­tion: 26/06/2008 · GP: Boehringer Ingelheim RCV GmbH · LP: Boehringer Ingelheim Auslandsbeteiligungs GmbH, Boehringer Ingelheim International GmbH · Address …
There are no publications matching your search.

Mentions

24 Apr 2026 in Ler
Direct parent
24 Apr 2026 in Ler
Ultimate parent
14 Oct 2025 in Rik
Branch office: Boehringer Ingelheim RCV GmbH & Co. KG Eesti filiaal
17 Oct 2018 in Ler
No longer Direct parent: Boehringer Ingelheim RCV Holding GmbH
9 Aug 2014 in Bmjfbv also 01/11/2013
Shareholding: Boehringer Ingelheim RCV Holding GmbH
12 Jul 2008 in Bmjfbv
Shareholding: Boehringer Ingelheim Pharma GmbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.